Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal

Thyroid

Volumn 19, Issue 1, 2009, Pages 13-20

  Huang, Shu Chuan ^a   Wu, Vin Cent ^b   Lin, Shih Yi ^a,c   Sheu, Wayne Huey Herng ^a   Song, Yuh Min ^c   Lin, Yen Hung ^b   Wu, Cheng Chung ^c   Chang, Wen Dau ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG WITHDRAWAL; EUTHYROIDISM; FEMALE; FREE LIOTHYRONINE INDEX; GLUCOSE HOMEOSTASIS; HUMAN; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIOTHYRONINE BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT WITHDRAWAL; ZULEWSKI SCORE;

ADULT; BODY MASS INDEX; CARCINOMA, PAPILLARY, FOLLICULAR; CHOLESTEROL; FEMALE; HOMEOSTASIS; HUMANS; HYPOTHYROIDISM; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THYROID HORMONES; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; THYROXINE; TRIGLYCERIDES; TRIIODOTHYRONINE;

EID: 58149237704     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0002     Document Type: Article

References (47)

1. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803.
2. Maxon HR, 3rd, Smith HS 1990 Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 19: 685-718.
3. Duntas LH, Biondi B 2007 Short-term hypothyroidism after levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences. Eur J Endocrinol 156:13-19.
4. Biondi B, Klein I 2004 Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24:1-13.
5. Duntas LH 2002 Thyroid disease and lipids. Thyroid 12:287-293.
6. Cappola AR, Ladenson PW 2003 Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 88:2438-2444.
7. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306.
8. Meier C, Trittibach P, Guglielmetti M, Staub JJ, Muller B 2003 Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey. BMJ 326:311-312.
9. Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ 1997 Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 82:771-776.
10. Escobar del Rey F, Ruiz de Ona C, Bernal J, Obregon MJ, Morreale de Escobar G 1989 Generalized deficiency of 3,5,3′-triiodo-L-thyronine (T3) in tissues from rats on a low iodine intake, despite normal circulating T3 levels. Acta Endocrinol (Cph) 120:490-498.
11. Tjorve E, Tjorve KM, Olsen JO, Senum R, Oftebro H 2007 On commonness and rarity of thyroid hormone resistance: a discussion based on mechanisms of reduced sensitivity in peripheral tissues. Med Hypotheses 69:913-921.
12. Garrison RL, Breeding PC 2003 A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses 61:182-189.
13. Fernandez-Real JM, Lopez-Bermejo A, Castro A, Casamitjana R, Ricart W 2006 Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab 91:3337-3343.
14. Dessein PH, Joffe BI, Stanwix AE 2004 Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid 14:443-446.
15. Masoudi FA, Baillie CA, Wang Y, Bradford WD, Steiner JF, Havranek EP, Foody JM, Krumholz HM 2005 The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med 165:2069-2076.
16. Sato Y, Iwamoto J, Kanoko T, Satoh K 2005 Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med 165:1743-1748.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419.
18. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502.
19. Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Muller B 2001 TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 86:4860-4866.
20. Roos A, Linn-Rasker SP, van Domburg RT, Tijssen JP, Berghout A 2005 The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med 165:1714-1720.
21. Walsh JP, Ward LC, Burke V, Bhagat CI, Shiels L, Henley D, Gillett MJ, Gilbert R, Tanner M, Stuckey BG 2006 Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial. J Clin Endocrinol Metab 91:2624-2630.
22. Botella-Carretero JI, Galan JM, Caballero C, Sancho J, Escobar-Morreale HF 2003 Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 10:601-610.
23. Greene FL, Page DL, Fleming ID 2003 AJCC Cancer Staging Manual, sixth edition. Springer-Verlag, Chigago, IL.
24. Meier CA, Braverman LE, Ebner SA, Veronikis I, Daniels GH, Ross DS, Deraska DJ, Davies TF, Valentine M, DeGroot LJ, et al. 1994 Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab 78:188-196.
25. Billewicz WZ, Chapman RS, Crooks J, Day ME, Gossage J, Wayne E, Young JA 1969 Statistical methods applied to the diagnosis of hypothyroidism. Q J Med 38:255-266.
26. Bando Y, Ushiogi Y, Okafuji K, Toya D, Tanaka N, Miura S 2002 Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction. Exp Clin Endocrinol Diabetes 110:408-415.
27. Lim VS, Fang VS, Katz AI, Refetoff S 1977 Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest 60:522-534.
28. Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, Regnier D, Dreyfus G, Pradier C, Sadoul JL, et al. 1993 High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 18:253-257.
29. Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG, Psyrogiannis AI, Kalfarentzos FE, Kyriazopoulou VE 2006 Thyroid function in humans with morbid obesity. Thyroid 16:73-78.
30. de Jong M, Docter R, van Der Hoek HJ, Vos RA, Krenning EP, Hennemann G 1992 Transport of 3,5,3′-triiodothyronine into the perfused rat liver and subsequent metabolism are inhibited by fasting. Endocrinology 131:463-470.
31. Gavin LA, Cavalieri RR, Moeller M 1987 Glucose and insulin reverse the effects of fasting on 3,5,3′-triiodothyronine neogenesis in primary cultures of rat hepatocytes. Endocrinology 121:858-864.
32. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ 2001 Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 22:451-476.
33. Hennemann G, Krenning EP, Polhuys M, Mol JA, Bernard BF, Visser TJ, Docter R 1986 Carrier-mediated transport of thyroid hormone into rat hepatocytes is rate-limiting in total cellular uptake and metabolism. Endocrinology 119:1870-1872.
34. Martinez-deMena R, Obregon MJ 2005 Insulin increases the adrenergic stimulation of 5′ deiodinase activity and mRNA expression in rat brown adipocytes; role of MAPK and PI3K. J Mol Endocrinol 34:139-151.
35. O'Mara BA, Dittrich W, Lauterio TJ, St. Germain DL 1993 Pretranslational regulation of type I 5′-deiodinase by thyroid hormones and in fasted and diabetic rats. Endocrinology 133:1715-1723.
36. Viguerie N, Langin D 2003 Effect of thyroid hormone on gene expression. Curr Opin Clin Nutr Metab Care 6:377-381.
37. Yen PM 2001 Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142.
38. Hu RM, Wu LM, Frank HJ, Pedram A, Levin ER 1994 Insulin stimulates thyroid hormone receptor alpha gene expression in cultured bovine aortic endothelial cells. Mol Cell Endocrinol 103:65-71.
39. Jolin T 1987 Diabetes decreases liver and kidney nuclear 3,5,3′-triiodothyronine receptors in rats. Endocrinology 120:2144-2151.
40. Wartofsky L, Latham KR, Djuh YY, Burman KD 1981 Alterations in T3 and T4 receptor binding in fasting and diabetes mellitus. Life Sci 28:1683-1691.
41. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G 2001 Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745-E751.
42. Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM 1995 Soluble cytokine receptors and the low 3,5,3′-triiodothyronine syndrome in patients with nonthyroidal disease. J Clin Endocrinol Metab 80:971-976.
43. Jakobs TC, Mentrup B, Schmutzler C, Dreher I, Kohrle J 2002 Proinflammatory cytokines inhibit the expression and function of human type I 5′-deiodinase in HepG2 hepatocarcinoma cells. Eur J Endocrinol 146:559-566.
44. Krassas GE, Pontikides N, Loustis K, Koliakos G, Constantinidis T, Kaltsas T 2006 Resistin levels are normal in hypothyroidism and remain unchanged after attainment of euthyroidism: relationship with insulin levels and anthropometric parameters. J Endocrinol Invest 29:606-612.
45. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR 2005 Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115:2524-2533.
46. Flamant F, Samarut J 2003 Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab 14:85-90.
47. Zhang J, Lazar MA 2000 The mechanism of action of thyroid hormones. Annu Rev Physiol 62:439-466.